Delivery Order SPE2DB22D2103-SPE2DB25FR9QX
- Not listed
- The Defense Logistics Agency (DLA) awarded a $7,941.41 delivery order to AmerisourceBergen Drug Corp for HYZAAR 100-12.5 tablets (90-count units) on July 30, 2025, with completion targeted for July 31, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a pharmaceutical supply requirement supporting federal medical procurement...
- The Defense Logistics Agency awarded a $3,928.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for HYZAAR 50-12.5 tablets (30 count) on September 8, 2025, with an ultimate completion date of September 9, 2025. This is a non-set-aside, competitively awarded contract supporting federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for military and veteran healthcare systems...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of HYZAAR 50-12.5 tablets (30-count units) valued at $3,693.91. This delivery order represents a firm fixed-price contract with an ultimate completion date of September 10, 2025, and was awarded on a competitive basis without set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,464.33 to AmerisourceBergen Drug Corp for the supply of HYZAAR 50-12.5 tablets (90-count units) under a firm fixed price contract. The award was issued on July 18, 2025, with an ultimate completion date of July 21, 2025. This non-set-aside delivery order was competitively awarded and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine...
- The Defense Logistics Agency awarded a delivery order valued at $1,504.02 to AmerisourceBergen Drug Corp for the supply of HYZAAR 50-12.5 tablets (30-count units). This competitive award, issued on July 30, 2025, with an ultimate completion date of July 31, 2025, represents a firm fixed-price transaction with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a $2,155.66 delivery order to AmerisourceBergen Drug Corp for 90 tablets of HYZAAR 100-12.5, a combination antihypertensive medication, with an ultimate completion date of August 28, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award issued on August 27, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a $2,297.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30-count tablets of Hyzaar 50-12.5, a combination antihypertensive medication. This non-set-aside competitive award was issued on September 3, 2025, with an ultimate completion date of September 4, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,311.68, is for the delivery of HYZAAR 50-12.5 TABLET 30S, a pharmaceutical product. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency awarded a $15,164.14 delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Hyzaar 50-12.5 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 28, 2025. The contract is being performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of HYZAAR 50-12.5 tablets. The order has a completion date of January 31, 2024 and a potential value of $1,294.97. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued at up...
- SPE2DB22D2103Indefinite Delivery Contract
- SPE2DB22D2103-SPE2DB25FR9QXDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for HYZAAR 50-12.5 tablets (a combination antihypertensive medication) in the quantity of 30 units, with a ceiling value of $1,059.30. This competitively awarded, firm fixed-price delivery order was executed on August 11, 2025, with an ultimate completion date of August 12, 2025. The contract is classified as a child award, indicating it derives from a larger contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed this work at its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to support military healthcare programs worldwide. The DLA Troop Support Medical supply chain represents a critical component of the Defense Health Agency's pharmaceutical procurement strategy, and AmerisourceBergen Drug Corp's role as a prime vendor demonstrates its capability to meet federal medical supply requirements through open competition across diverse therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/11/25 |